首页> 外文OA文献 >Phase I/II study of the pharmacokinetics, safety and efficacy of S-1 in patients with advanced hepatocellular carcinoma

【2h】

Phase I/II study of the pharmacokinetics, safety and efficacy of S-1 in patients with advanced hepatocellular carcinoma

机译：肝癌患者患者的药代动力学，S-1的药代动力学，安全性和疗效的阶段I / II研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Junji Furuse; Takuji Okusaka; Shuichi Kaneko; Masatoshi Kudo; Kohei Nakachi; Hideki Ueno; Tatsuya Yamashita; Kazuomi Ueshima;
展开▼
作者单位

展开▼
年度 2010
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Phase I/II study of the pharmacokinetics, safety and efficacy of S-1 in patients with advanced hepatocellular carcinoma [J] . Junji Furuse, Takuji Okusaka, Shuichi Kaneko, Cancer Science . 2010,第12期

机译：I / II期S-1在晚期肝细胞癌患者中的药代动力学，安全性和疗效研究
2. Phase I/II study of the pharmacokinetics, safety and efficacy of S-1 in patients with advanced hepatocellular carcinoma [J] . Junji Furuse, Takuji Okusaka, Shuichi Kaneko, Cancer science. . 2010,第12期

机译：I / II期S-1在晚期肝细胞癌患者中的药代动力学，安全性和疗效研究
3. Phase I/II study of the pharmacokinetics, safety and efficacy of S-1 in patients with advanced hepatocellular carcinoma. [J] . Furuse J, Okusaka T, Kaneko S, Cancer science. . 2010,第12期

机译：肝癌患者患者的药代动力学，S-1的药代动力学，安全性和疗效的研究。
4. Efficacy Analysis of Preservative-Free Tafluprost and Timolol in Open-Angle Glaucoma and OHT Patients in a Phase-III Study [C] . GrundenJ., Lupinacci R. International Symposium on Ocular Pharmacology and Therapeutics . 2013

机译：在第三阶段研究中，在开放角度荧光眼和OHT患者中无防腐型TaFluprost和蒂莫尔的疗效分析
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. Phase I study on the safety pharmacokinetic profile and efficacy of the combination of TSU-68 an oral antiangiogenic agent and S-1 in patients with advanced hepatocellular carcinoma [O] . Masafumi Ikeda, Shuichiro Shiina, Kohei Nakachi, -1

机译：一期研究：口服抗血管生成剂TSU-68和S-1联合治疗晚期肝细胞癌的安全性药代动力学和疗效
7. Phase I study on the safety, pharmacokinetic profile, and efficacy of the combination of TSU-68, an oral antiangiogenic agent, and S-1 in patients with advanced hepatocellular carcinoma [O] . 2014

机译：一期研究：口服抗血管生成剂TSU-68和S-1联合治疗晚期肝细胞癌的安全性，药代动力学和疗效

Phase I/II study of the pharmacokinetics, safety and efficacy of S-1 in patients with advanced hepatocellular carcinoma

著录项

引文网络

相似文献

相关主题

期刊订阅